Although, the built-in adjuvant used was predicted to lack IFN-γ-inducing epitopes which are important for immune protection in onchocerciasis, the mechanism of action of this adjuvant as is yet to be elucidated. The gene discussed is IFNG; the disease is onchocerciasis.